5-38527126-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127671.2(LIFR):​c.397+29A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.435 in 1,553,396 control chromosomes in the GnomAD database, including 152,324 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 12466 hom., cov: 32)
Exomes 𝑓: 0.44 ( 139858 hom. )

Consequence

LIFR
NM_001127671.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.524

Publications

14 publications found
Variant links:
Genes affected
LIFR (HGNC:6597): (LIF receptor subunit alpha) This gene encodes a protein that belongs to the type I cytokine receptor family. This protein combines with a high-affinity converter subunit, gp130, to form a receptor complex that mediates the action of the leukemia inhibitory factor, a polyfunctional cytokine that is involved in cellular differentiation, proliferation and survival in the adult and the embryo. Mutations in this gene cause Schwartz-Jampel syndrome type 2, a disease belonging to the group of the bent-bone dysplasias. A translocation that involves the promoter of this gene, t(5;8)(p13;q12) with the pleiomorphic adenoma gene 1, is associated with salivary gland pleiomorphic adenoma, a common type of benign epithelial tumor of the salivary gland. Multiple splice variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2018]
LIFR Gene-Disease associations (from GenCC):
  • Stüve-Wiedemann syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Stüve-Wiedemann syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 5-38527126-T-G is Benign according to our data. Variant chr5-38527126-T-G is described in ClinVar as Benign. ClinVar VariationId is 1185227.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127671.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIFR
NM_001127671.2
MANE Select
c.397+29A>C
intron
N/ANP_001121143.1
LIFR
NM_001364297.2
c.397+29A>C
intron
N/ANP_001351226.1
LIFR
NM_002310.6
c.397+29A>C
intron
N/ANP_002301.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIFR
ENST00000453190.7
TSL:2 MANE Select
c.397+29A>C
intron
N/AENSP00000398368.2
LIFR
ENST00000263409.8
TSL:1
c.397+29A>C
intron
N/AENSP00000263409.4
LIFR
ENST00000503088.1
TSL:1
n.560+29A>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.386
AC:
58609
AN:
151992
Hom.:
12470
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.443
Gnomad AMR
AF:
0.341
Gnomad ASJ
AF:
0.642
Gnomad EAS
AF:
0.541
Gnomad SAS
AF:
0.465
Gnomad FIN
AF:
0.490
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.455
Gnomad OTH
AF:
0.432
GnomAD2 exomes
AF:
0.429
AC:
90598
AN:
211356
AF XY:
0.441
show subpopulations
Gnomad AFR exome
AF:
0.199
Gnomad AMR exome
AF:
0.250
Gnomad ASJ exome
AF:
0.638
Gnomad EAS exome
AF:
0.545
Gnomad FIN exome
AF:
0.480
Gnomad NFE exome
AF:
0.457
Gnomad OTH exome
AF:
0.459
GnomAD4 exome
AF:
0.440
AC:
616782
AN:
1401286
Hom.:
139858
Cov.:
27
AF XY:
0.444
AC XY:
309546
AN XY:
696510
show subpopulations
African (AFR)
AF:
0.198
AC:
6395
AN:
32280
American (AMR)
AF:
0.262
AC:
10571
AN:
40300
Ashkenazi Jewish (ASJ)
AF:
0.635
AC:
16020
AN:
25232
East Asian (EAS)
AF:
0.552
AC:
21344
AN:
38648
South Asian (SAS)
AF:
0.471
AC:
38539
AN:
81784
European-Finnish (FIN)
AF:
0.476
AC:
24603
AN:
51634
Middle Eastern (MID)
AF:
0.549
AC:
3051
AN:
5556
European-Non Finnish (NFE)
AF:
0.440
AC:
470161
AN:
1067904
Other (OTH)
AF:
0.450
AC:
26098
AN:
57948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
14745
29490
44236
58981
73726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14018
28036
42054
56072
70090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.385
AC:
58606
AN:
152110
Hom.:
12466
Cov.:
32
AF XY:
0.390
AC XY:
28968
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.206
AC:
8571
AN:
41510
American (AMR)
AF:
0.341
AC:
5207
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.642
AC:
2226
AN:
3468
East Asian (EAS)
AF:
0.540
AC:
2792
AN:
5166
South Asian (SAS)
AF:
0.464
AC:
2238
AN:
4824
European-Finnish (FIN)
AF:
0.490
AC:
5180
AN:
10576
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.455
AC:
30929
AN:
67964
Other (OTH)
AF:
0.428
AC:
903
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1759
3517
5276
7034
8793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.438
Hom.:
11524
Bravo
AF:
0.366
Asia WGS
AF:
0.479
AC:
1668
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Stuve-Wiedemann syndrome Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.9
DANN
Benign
0.64
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289779; hg19: chr5-38527228; COSMIC: COSV54686598; COSMIC: COSV54686598; API